Related Experiment Videos
Neuroinflammation in Alzheimer's disease and prion disease
P Eikelenboom1,2, C Bate3, W A Van Gool2
1Department of Psychiatry, Graduate School of Neurosciences, Vrije Universiteit Medical Center, Amsterdam, The Netherlands.
Glia
|October 16, 2002
Summary
Alzheimer
Area of Science:
- Neurodegenerative diseases
- Neuroinflammation
- Amyloidosis
Background:
- Alzheimer's disease (AD) and prion diseases feature amyloid deposits and chronic inflammation.
- Activated microglia and inflammatory proteins are present in both conditions.
- Genetic factors influence AD risk, but their role in prion disease is less clear.
Purpose of the Study:
- To review similarities and differences in inflammatory mechanisms between AD and prion disease.
- To discuss the early involvement of inflammation in both neurodegenerative disorders.
- To explore potential therapeutic strategies targeting neuroinflammation.
Main Methods:
- Review of clinicopathological and neuroradiological studies.
- Analysis of epidemiological data and transgenic mouse models.
- Comparison of inflammatory protein and microglial activation patterns.
Main Results:
- Cerebral amyloid deposits in AD and prion disease are linked to chronic inflammatory responses.
- Microglial activation is an early event in both diseases, preceding neuronal damage.
- While acute-phase proteins influence AD amyloid formation, their role in prion disease is uncertain.
Conclusions:
- Inflammation is an early, common pathway in Alzheimer's and prion diseases.
- Targeting these early inflammatory processes may offer therapeutic benefits.
- Further research is needed to clarify the specific roles of inflammatory mediators.